In a post-hoc analysis of the ALLEGRO phase 2b/3 trial, researchers evaluated whether scalp, eyebrow, and eyelash hair regrowth would continue over 48 weeks in patients with alopecia areata treated with...
In a recent study presented at the American Academy of Dermatology’s annual meeting, researchers examined the efficacy of various doses of an oral JAK1/JAK2 inhibitor for treating patients with...
Researchers evaluated the efficacy of Janus kinase inhibitors in adult patients with alopecia areata. Their research was presented at the American Academy of Dermatology’s 2023 annual meeting in New...
The American Gastroenterological Association (AGA) released a set of guidelines that outlines the use of biomarkers to treat and monitor ulcerative colitis in patients.
In this article, Michael J. Bloch, MD, writes about the results of the recently published BrightHTN study, which examined the use of the investigational aldosterone synthase inhibitor baxdrostat in patients...
Researchers determined the impact of melanoma subtypes on cutaneous immune-related adverse events and survival among those who received immune checkpoint inhibitor therapy.
